Preventing nausea after gallbladder surgery: comparing two drug combos
Part of Digestive system clinical trials.
This trial compares two combinations of medicines to prevent nausea and vomiting after gallbladder surgery. If you are a woman having keyhole gallbladder surgery, you may be eligible for extra nausea prevention with either granisetron plus dexamethasone or granisetron plus metoclopramide.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 60 years old.
- You are a non-smoker.
- You are scheduled to have your gallbladder removed by keyhole surgery (laparoscopic cholecystectomy).
- You do not have any severe liver or kidney problems.
- You are not pregnant or breastfeeding.
- You are not allergic to the study drugs (granisetron, dexamethasone, metoclopramide).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new pain medicine (Tegileridine) against a standard one (Sufentanil) during laparoscopic surgery. It is for patients who have a high risk of nausea and vomiting after surgery.
This study compares two common medicines given during surgery to prevent nausea and vomiting in children. It aims to find out which one works better and is safer.
This study tests two different medication combinations to prevent nausea and vomiting after laparoscopic gallbladder removal surgery. You'll receive either ondansetron plus metoclopramide, or dexamethasone plus metoclopramide, and researchers will track how quickly you need rescue medication if nausea occurs.
This study compares two different sedative medications used during anesthesia to see which one helps prevent nausea and vomiting after gallbladder removal surgery. Participating may help you recover more comfortably after your procedure.
This trial tests a combination of three medicines given during surgery to reduce nausea and vomiting after anesthesia. You might be eligible if you’re having laparoscopic gynecologic surgery and meet the age and health requirements.
This trial tests if adding HRS5580 to standard anti-nausea medicine works better to stop vomiting after surgery. You may qualify if you are at moderate-to-high risk for nausea after general anesthesia.
Hear when a new Postoperative Nausea and Vomiting (PONV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.